IL133647A0 - Novel cd44 variant - Google Patents

Novel cd44 variant

Info

Publication number
IL133647A0
IL133647A0 IL13364799A IL13364799A IL133647A0 IL 133647 A0 IL133647 A0 IL 133647A0 IL 13364799 A IL13364799 A IL 13364799A IL 13364799 A IL13364799 A IL 13364799A IL 133647 A0 IL133647 A0 IL 133647A0
Authority
IL
Israel
Prior art keywords
novel
transcript
variant
found
exon
Prior art date
Application number
IL13364799A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL13035699A external-priority patent/IL130356A0/xx
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL13364799A priority Critical patent/IL133647A0/xx
Priority to AT00935449T priority patent/ATE445012T1/de
Priority to EP00935449A priority patent/EP1187917B1/de
Priority to PCT/IL2000/000326 priority patent/WO2000075312A1/en
Priority to DE60043104T priority patent/DE60043104D1/de
Priority to AU50988/00A priority patent/AU5098800A/en
Publication of IL133647A0 publication Critical patent/IL133647A0/xx
Priority to US10/012,969 priority patent/US20030108984A1/en
Priority to US11/130,206 priority patent/US7534605B2/en
Priority to US12/230,899 priority patent/US7883857B2/en
Priority to US12/230,900 priority patent/US7901909B2/en
Priority to US13/021,807 priority patent/US8193311B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13364799A 1999-06-08 1999-12-21 Novel cd44 variant IL133647A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IL13364799A IL133647A0 (en) 1999-06-08 1999-12-21 Novel cd44 variant
AU50988/00A AU5098800A (en) 1999-06-08 2000-06-07 Cd44 splice variant associated with rheumatoid arthritis
DE60043104T DE60043104D1 (de) 1999-06-08 2000-06-07 Mit rheumatischer arthritis assoziierte spleissvariante von cd44
EP00935449A EP1187917B1 (de) 1999-06-08 2000-06-07 Mit rheumatischer arthritis assoziierte spleissvariante von cd44
PCT/IL2000/000326 WO2000075312A1 (en) 1999-06-08 2000-06-07 Cd44 splice variant associated with rheumatoid arthritis
AT00935449T ATE445012T1 (de) 1999-06-08 2000-06-07 Mit rheumatischer arthritis assoziierte spleissvariante von cd44
US10/012,969 US20030108984A1 (en) 1999-06-08 2001-12-07 CD44 splice variant associated with rheumatoid arthritis
US11/130,206 US7534605B2 (en) 1999-06-08 2005-05-17 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US12/230,899 US7883857B2 (en) 1999-06-08 2008-09-08 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US12/230,900 US7901909B2 (en) 1999-06-08 2008-09-08 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US13/021,807 US8193311B2 (en) 1999-06-08 2011-02-07 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13035699A IL130356A0 (en) 1999-06-08 1999-06-08 Novel CD44 variant
IL13364799A IL133647A0 (en) 1999-06-08 1999-12-21 Novel cd44 variant

Publications (1)

Publication Number Publication Date
IL133647A0 true IL133647A0 (en) 2001-04-30

Family

ID=26323849

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13364799A IL133647A0 (en) 1999-06-08 1999-12-21 Novel cd44 variant

Country Status (7)

Country Link
US (1) US20030108984A1 (de)
EP (1) EP1187917B1 (de)
AT (1) ATE445012T1 (de)
AU (1) AU5098800A (de)
DE (1) DE60043104D1 (de)
IL (1) IL133647A0 (de)
WO (1) WO2000075312A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534605B2 (en) * 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
CA2441206A1 (en) 2001-03-19 2002-09-26 Gyros Ab Characterization of reaction variables
AU2002326112A1 (en) * 2001-08-09 2003-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Cd44 variants carrying heparan sulfate chains and uses thereof
DE60316106T2 (de) * 2002-01-09 2008-05-29 Faron Pharmaceuticals Oy Gemeinsamer lymphatischer endothel- und gefässendothel-rezeptor-1 (clever-1) und seine verwendung
ATE533788T1 (de) * 2003-07-15 2011-12-15 Yissum Res Dev Co Antikörper gegen cd44vra und methoden zu ihrer verwendung
JP4459179B2 (ja) * 2005-03-30 2010-04-28 株式会社東芝 情報処理装置及びその方法
US20060294607A1 (en) * 2006-03-29 2006-12-28 Applera Corporation Human podocalyxin alternative-spliced forms and uses thereof
WO2009007934A2 (en) * 2007-07-10 2009-01-15 Neurim Pharmaceuticals (1991) Ltd. Cd44 splice variants in neurodegenerative diseases
WO2010058396A1 (en) * 2008-11-19 2010-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A cd44vra antibody and diagnostic and therapeutic methods using same
HUE049261T2 (hu) 2014-07-15 2020-09-28 Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd CD44 izolált polipeptidek és alkalmazásaik
WO2024093147A1 (zh) * 2022-10-31 2024-05-10 南京元迈细胞生物科技有限公司 一种特异性结合CD44的v5外显子的抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH735H (en) * 1988-03-30 1990-02-06 The United States Of America As Represented By The United States Department Of Energy Lead-203 as a label for radioimaging
AU5543594A (en) * 1992-10-30 1994-05-24 Duke University An adhesion molecule
CA2164728A1 (en) * 1993-06-22 1995-01-05 Helmut Ponta Processes for diagnosing and analysing tumours
DE19708713C2 (de) * 1997-03-04 2002-11-28 Boehringer Ingelheim Int Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen
ATE533788T1 (de) * 2003-07-15 2011-12-15 Yissum Res Dev Co Antikörper gegen cd44vra und methoden zu ihrer verwendung

Also Published As

Publication number Publication date
WO2000075312A1 (en) 2000-12-14
EP1187917A1 (de) 2002-03-20
EP1187917B1 (de) 2009-10-07
DE60043104D1 (de) 2009-11-19
US20030108984A1 (en) 2003-06-12
AU5098800A (en) 2000-12-28
ATE445012T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
Devlin et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia
Asl et al. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis
Thweatt et al. A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts
AU5098800A (en) Cd44 splice variant associated with rheumatoid arthritis
EP0753580A3 (de) Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinase-3"
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
DE60037800D1 (de) Stereoselektive antifibrillogene peptide
WO2004045553A3 (en) Ca125 gene and its use for diagnostic and therapeutic interventions
PT910647E (pt) Variantes hiperactivas da dnase i humana
US6316597B1 (en) Sox-9 gene and protein and use in the regeneration of bone or cartilage
PT1000146E (pt) Ests 5' para proteinas secretadas sem especificidade tecidular
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
AU2095097A (en) Direct molecular diagnosis of friedreich ataxia
BR9607336A (pt) Composições de aminoácidos e utilidades das mesmas em nutrição clinica
US20100273158A1 (en) HIN-1, A Tumor Suppressor Gene
DE69735020D1 (de) Verfahren zur Diagnose von Prostatakrebs
WO2003072598A3 (en) Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
WO1997044454A3 (en) Human phospholipase inhibitor
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
NO993653D0 (no) Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer
US20040018188A9 (en) Sparc-related proteins
WO1999047655A3 (de) Menschliche nukleinsaeurefragmente, deren expression in brustnormalgewebe erhöht ist
Lund et al. Cloning and sequencing of the bovine gastrin gene
Nuytinck et al. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the α2 (I) collagen chain
BG102878A (en) The use of genetic change in the gene of the human g-protein, 3-subunit for the diagnostics of diseases